18F-FDG semi-quantitative parameters and biological prognostic factors in locally advanced breast cancer
- 31 December 2012
- journal article
- clinical trial
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular
- Vol. 31 (6) , 308-314
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factorsInternational Journal of Clinical Oncology, 2010
- 18F-FDG PET of Locally Invasive Breast Cancer and Association of Estrogen Receptor Status with Standardized Uptake Value: Microarray and Immunohistochemical AnalysisJournal of Nuclear Medicine, 2010
- 18F‐fluorodeoxyglucose positron emission tomography/computed tomography (FDG‐PET/CT) imaging in the staging and prognosis of inflammatory breast cancerCancer, 2009
- Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancerBritish Journal of Surgery, 2009
- Clinicopathological and Prognostic Relevance of Uptake Level using 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) in Primary Breast CancerJapanese Journal of Clinical Oncology, 2008
- Comparison of triple‐negative and estrogen receptor‐positive/progesterone receptor‐positive/HER2‐negative breast carcinoma using quantitative fluorine‐18 fluorodeoxyglucose/positron emission tomography imaging parametersCancer, 2007
- The Effects of Estrogen, Progesterone, and C-erbB-2 Receptor States on 18F-FDG Uptake of Primary Breast Cancer LesionsJournal of Nuclear Medicine, 2007
- [18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2007
- Clinicopathologic factors associated with false negative FDG–PET in primary breast cancerBreast Cancer Research and Treatment, 2006
- 18F-2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography in Staging of Locally Advanced Breast CancerJournal of Clinical Oncology, 2004